A Study of the Oral EGFR Inhibitor PLB1004 in Non-Small Cell Lung Cancer

Condition:   Non-Small Cell Lung Cancer Intervention:   Drug: PLB1004 Sponsor:   Avistone Biotechnology Co., Ltd. Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials